Skip to main content

Table 2 Treatment outcome of MDR-TB patient notified between 2011 and 2013

From: Treatment outcome of multidrug-resistant tuberculosis in Japan – the first cross-sectional study of Japan tuberculosis surveillance data

Notification year 2011 2012 2013 2011–2013
Evaluation year End of 2013 End of 2016 End of 2014 End of 2016 End of 2015 End of 2016 End of 2016
Total (%) 59 (100.0) 59 (100.0) 64 (100.0) 64 (100.0) 49 (100.0) 49 (100.0) 172 (100.0)
Treatment completed 32 (54.2) 35 (59.3) 30 (46.9) 33 (51.6) 25 (51.0) 30 (61.2) 98 (57.0)
Treatment stopped (adverse effects) 4 (6.8) 4 (6.8) 2 (3.1) 2 (3.1) 2 (4.1) 2 (4.1) 8 (4.7)
Treatment stopped (other reasons) 1 (1.7) 1 (1.7) 1 (1.6) 1 (1.6) 0 (0.0) 0 (0.0) 2 (1.2)
Died (TB) 9 (15.3) 9 (15.3) 7 (10.9) 8 (12.5) 5 (10.2) 5 (10.2) 22 (12.8)
Died (non-TB) 5 (8.5) 5 (8.5) 10 (15.6) 10 (15.6) 5 (10.2) 5 (10.2) 20 (11.6)
Still on treatment 4 (6.8) 0 (0.0) 6 (9.4) 1 (1.6) 5 (10.2) 0 (0.0) 1 (0.6)
Transferred out 4 (6.8) 4 (6.8) 5 (7.8) 6 (9.4) 7 (14.3) 7 (14.3) 17 (9.9)
Unknown 0 (0.0) 1 (1.7) 1 (1.6) 1 (1.6) 0 (0.0) 0 (0.0) 2 (1.2)
Treatment not started 0 (0.0) 0 (0.0) 2 (3.1) 2 (3.1) 0 (0.0) 0 (0.0) 2 (1.2)